database,submission_date,release_date,last_update_date,title,accession,type,source,organism,neonate,gender,tissue,on antibiotics at time of sample,bloodculture result,other positive results,corrected gestational age (weeks+days),birthweight (g),molecule,extract_protocol,label,label_protocol,hybridization_protocol,scan_protocol,description,data_processing,corrected gestational age at sample (weeks+days)
GEO,2010-11-19,2014-08-12,2016-06-14,Con001,GSM627008,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,34+6,1715,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con017,GSM627009,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,40+6,3250,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con021,GSM627010,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,40+5,3440,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con022,GSM627011,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,41+6,2990,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con028,GSM627012,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,36+5,2370,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con029,GSM627013,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,39+6,2940,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con040,GSM627014,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,40+0,2800,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con042,GSM627015,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,"umbilical swab grew anaerobes, coliforms, Saureus and gp B strep",42+5,3980,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con043,GSM627016,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,42+5,3980,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con046,GSM627017,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,41+6,3500,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con048,GSM627018,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,39+6,4590,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con049,GSM627019,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,41+5,4140,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con051,GSM627020,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,39+5,3020,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con058,GSM627021,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,39+5,4120,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con062,GSM627022,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,no. blood culture 3 days previously negative,41+6,4270,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con063,GSM627023,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,44+1,3309,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con065,GSM627024,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,42+1,3620,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con067,GSM627025,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,39+4,2225,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con069,GSM627026,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,40+2,3510,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con071,GSM627027,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,42+6,4300,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con072,GSM627028,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,41+0,4370,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con073,GSM627029,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,well. 3 days later had Saureus in wound swab.,37+0,1880,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con077,GSM627030,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,41+6,3630,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con079,GSM627031,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,40+1,3440,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con081,GSM627032,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,41+4,3500,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con086,GSM627033,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,43+1,3820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con087,GSM627034,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,34+2,2200,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con096,GSM627035,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,37+5,3700,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con097,GSM627036,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,42+6,4301,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con165,GSM627037,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,30+3,930,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con181,GSM627038,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,No,na,No,33+6,670,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con200,GSM627039,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,35+2,1115,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con202,GSM627040,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,35+5,1600,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con206,GSM627041,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,32+3,1225,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Con207,GSM627042,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,No,na,No,42+0,4200,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf009,GSM627043,RNA,peripheral blood,Homo sapiens,control,Female,peripheral blood,Yes,Coagulase negative staphylococcus,"coag neg staph long line tip next day, previous ureaplasma,,no previous positive blood cultures",32+5,720,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf047,GSM627044,RNA,peripheral blood,Homo sapiens,control,Male,peripheral blood,Yes,candida,"klebsiella in peritoneal fluid and ET secretions, NEC 1 week previously, candida in blood 4 days previously",30+5,1380,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf075,GSM627045,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,No,negative,CMV in blood and urine,36+4,890,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,"Corrected_gestational_age_(weeks+days):36+4
Birthweight_(g):890","Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf082,GSM627046,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,positive (enterobacter cloacae),enterobacter cloacae (also 1 week post sample),30+1,1230,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf083,GSM627047,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,Positive (E faecium),Blood cultures 3 days before and 2 days after also E faecium,34+1,1405,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf084,GSM627048,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,Positive (coag neg staph),CSF coag neg staph.  Also from day before long line tip and BC grew coag neg staph,29+3,720,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf089,GSM627049,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,positive (coag neg staph),CSF and urine negative,28+2,850,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf091,GSM627050,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,No,Positive (Group B Strep),CSF negative,38+1,3900,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf102,GSM627051,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,Positive (pseudomonas aeuruginosa and coag neg staph),"Blood culture positive for pseudomonas and coag neg staph, coag neg staph also present in blood cultures x 2 in previous week and also the next day",31+3,785,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf111,GSM627052,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,Coagulase negative staphylococcus,2 blood cultures coag neg staph,30+0,1200,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf112,GSM627053,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,No,Positive(group B strep),CSF coag neg staph,25+3,660,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf114,GSM627054,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,No,Positive(coag neg staph),"long line tip coag neg staph, previous day ETT tip and ETS Ecoli/coliforms",27+2,955,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf116,GSM627055,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,negative,aspirate of abscess grew coag neg staph,30+0,720,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf119,GSM627056,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,Coagulase negative staphylococcus,No,30+2,983,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf125,GSM627057,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,Postive (coag neg staph),blood culture 5 days previous grew coag neg staph,29+5,983,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf132,GSM627058,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,Positive (E faecalis),blood culture 2 and 4 days previously and next day also enterococcus,29+2,1100,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf133,GSM627059,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,Coagulase negative staphylococcus,No,27+4,1140,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf138,GSM627060,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,Positive (coag neg staph),No,27+2,870,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf145,GSM627061,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,Enterococcus faecalis,No,28+5,1100,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf149,GSM627062,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,negative,1cfu Klebsiells in CSF,29+1,840,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf152,GSM627063,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,Yes,positive(coag neg staph),"blood culture 3 days previous 2 strains coag neg staph, line tip 2 days previous mixed coag neg staph",31+0,450,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf157,GSM627064,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,No,Coagulase negative staphylococcus,No,31+3,820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf159,GSM627065,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,positive(enterococcus),"csf 1 no growth, 2 coag neg staph",31+2,1335,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf162,GSM627066,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,positive(coag neg staph),"2 separate blood cultures coag neg staph, csf no growth",27+6,1130,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf164,GSM627067,RNA,peripheral blood,Homo sapiens,infected,Female,peripheral blood,Yes,positive(kelbsiella oxytoca),not stated,31+5,820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf191,GSM627068,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,positive(E coli),csf no growth,37+0,2970,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf198,GSM627069,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,positive(coag neg staph),"csf no growth, note CoNeg Staph resistant to fluclox and gent which baby on further deterioration and repeat sample thoughâ€¦",33+1,1070,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2010-11-19,2014-08-12,2016-06-14,Inf203,GSM627070,RNA,peripheral blood,Homo sapiens,infected,Male,peripheral blood,No,Coagulase negative staphylococcus,No,37+0,1070,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays,Standard Illumina hybridization protocol,Standard Illumina scanning protocol,set:Training Set,"Raw scan data were background subtracted, VST transformed and subsequently robust spline normalised as performed by the lumi package of Bioconductor.  Array probe features that had a present count in one or more samples were retained.",
GEO,2014-06-04,2014-08-12,2016-06-14,Con006,GSM1404208,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,41+3,4240,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.,Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.,GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.",
GEO,2014-06-04,2014-08-12,2016-06-14,Con014,GSM1404209,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,no,38+3,2970,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.,Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.,GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.",
GEO,2014-06-04,2014-08-12,2016-06-14,Con030,GSM1404210,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,umbilical swab grew proteus (may represent colonisation),40+1,3270,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.,Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.,GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.",
GEO,2014-06-04,2014-08-12,2016-06-14,Inf012,GSM1404211,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"CSF: enterovirus on PCR.  CSF also grew coag neg staph, CSF WCC 300, RBC 9",34+6,2150,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.,Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.,GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.",
GEO,2014-06-04,2014-08-12,2016-06-14,Inf032,GSM1404212,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"yes CSF grew Listeria monocytogenes, CSF white cell count 551, RBC 119, urine no growth",41+1,3180,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.,Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.,GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.",
GEO,2014-06-04,2014-08-12,2016-06-14,Con209,GSM1404213,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,1120,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",37+4
GEO,2014-06-04,2014-08-12,2016-06-14,Con213,GSM1404214,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,890,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",30+5
GEO,2014-06-04,2014-08-12,2016-06-14,Con220,GSM1404215,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,1515,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",34+2
GEO,2014-06-04,2014-08-12,2016-06-14,Con260,GSM1404216,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",29+3
GEO,2014-06-04,2014-08-12,2016-06-14,Con270,GSM1404217,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,1875,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",32+5
GEO,2014-06-04,2014-08-12,2016-06-14,Con293,GSM1404218,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,,,855,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",29+3
GEO,2014-06-04,2014-08-12,2016-06-14,Inf216,GSM1404219,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,Enterococcus,,,810,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",34+3
GEO,2014-06-04,2014-08-12,2016-06-14,Inf226,GSM1404220,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,Enterococcus & Staph. warneri,BC next day grew Staphylococcus warneri,,1385,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",33+1
GEO,2014-06-04,2014-08-12,2016-06-14,Inf239,GSM1404221,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,Pseudomonas aeruginosa & Coagulase -ve Staph. aureus,"Next day, peritoneal swab enterococcus, pseudomonas aeruginosa and klebsiella oxytoca",,680,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",27+5
GEO,2014-06-04,2014-08-12,2016-06-14,Inf262,GSM1404222,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,Group B Strep.,,,690,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",39+6
GEO,2014-06-04,2014-08-12,2016-06-14,Inf271,GSM1404223,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Staph. epidermidis,grew yeasts 2 days later,,1040,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",35+6
GEO,2014-06-04,2014-08-12,2016-06-14,Inf275,GSM1404224,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Coagulase -ve Staph. aureus,,,1255,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",39+0
GEO,2014-06-04,2014-08-12,2016-06-14,Inf287,GSM1404225,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,E. coli,,,880,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",34+6
GEO,2014-06-04,2014-08-12,2016-06-14,Inf297,GSM1404226,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,Serratia marcescens,,,1490,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",35+4
GEO,2014-06-04,2014-08-12,2016-06-14,Inf299,GSM1404227,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Serratia marcescens,,,1490,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",36+2
GEO,2014-06-04,2014-08-12,2016-06-14,NEC253,GSM1404228,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,n/a,Coagulase -ve Staph. aureus previous day,,1390,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",36+2
GEO,2014-06-04,2014-08-12,2016-06-14,NEC283,GSM1404229,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,n/a,"Enterobacter cloacae, 6 days previously",,1490,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",31+5
GEO,2014-06-04,2014-08-12,2016-06-14,Vir228,GSM1404230,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,Rhinovirus PCR +ve,,1920,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",34+3
GEO,2014-06-04,2014-08-12,2016-06-14,Vir269,GSM1404231,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,CMV,,,1290,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",35+5
GEO,2014-06-04,2014-08-12,2016-06-14,Vir278,GSM1404232,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,n/a,Rhinovirus PCR +ve,,855,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,Biotinylated cRNA were prepared with the standard Affymetrix GeneChip GeneTitan 3' IVT labeling kit.,Standard Affymetrix GeneTitan 3' IVT hybridisation and wash procedure.,GeneChips were scanned using the Affymetrix GeneTitan Scanner using the GCOS software tool,Validation Test Set,"R/Bioconductor using RMA normalisation, non specific expression level filter of 50 applied and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed.",32+2
GEO,2014-06-04,2014-08-12,2016-06-14,Con001,GSM1404233,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,34+6,1715,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con017,GSM1404234,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,40+6,3250,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con028,GSM1404235,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,36+5,2370,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con042,GSM1404236,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,"umbilical swab grew anaerobes, coliforms, Saureus and gp B strep",42+5,3980,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con049,GSM1404237,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,41+5,4140,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con051,GSM1404238,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,39+5,3020,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con058,GSM1404239,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,39+5,4120,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con062,GSM1404240,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,no. blood culture 3 days previously negative,41+6,4270,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con063,GSM1404241,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,44+1,3309,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con065,GSM1404242,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,42+1,3620,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con067,GSM1404243,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,39+4,2225,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con069,GSM1404244,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,40+2,3510,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con071,GSM1404245,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,42+6,4300,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con072,GSM1404246,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,41+0,4370,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con073,GSM1404247,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,well. 3 days later had Saureus in wound swab.,37+0,1880,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con079,GSM1404248,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,40+1,3440,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con081,GSM1404249,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,41+4,3500,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con086,GSM1404250,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,43+1,3820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con087,GSM1404251,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,34+2,2200,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con096,GSM1404252,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,37+5,3700,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con165,GSM1404253,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,30+3,930,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con181,GSM1404254,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,No,33+6,670,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con200,GSM1404255,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,35+2,1115,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con202,GSM1404256,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,No,35+5,1600,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf047,GSM1404257,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,candida,"klebsiella in peritoneal fluid and ET secretions, NEC 1 week previously, candida in blood 4 days previously",30+5,1380,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf082,GSM1404258,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,positive (enterobacter cloacae),enterobacter cloacae (also 1 week post sample),30+1,1230,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf083,GSM1404259,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,Positive (E faecium),Blood cultures 3 days before and 2 days after also E faecium,34+1,1405,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf084,GSM1404260,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Positive (coag neg staph),CSF coag neg staph.  Also from day before long line tip and BC grew coag neg staph,29+3,720,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf089,GSM1404261,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,positive (coag neg staph),CSF and urine negative,28+2,850,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf091,GSM1404262,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,Positive (Group B Strep),CSF negative,38+1,3900,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf102,GSM1404263,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,Positive (pseudomonas aeuruginosa and coag neg staph),"Blood culture positive for pseudomonas and coag neg staph, coag neg staph also present in blood cultures x 2 in previous week and also the next day",31+3,785,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf112,GSM1404264,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,Positive(group B strep),CSF coag neg staph,25+3,660,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf114,GSM1404265,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,Positive(coag neg staph),"long line tip coag neg staph, previous day ETT tip and ETS Ecoli/coliforms",27+2,955,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf125,GSM1404266,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,Postive (coag neg staph),blood culture 5 days previous grew coag neg staph,29+5,983,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf132,GSM1404267,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Positive (E faecalis),blood culture 2 and 4 days previously and next day also enterococcus,29+2,1100,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf138,GSM1404268,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,Positive (coag neg staph),No,27+2,870,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf152,GSM1404269,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,positive(coag neg staph),"blood culture 3 days previous 2 strains coag neg staph, line tip 2 days previous mixed coag neg staph",31+0,450,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf159,GSM1404270,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,positive(enterococcus),"csf 1 no growth, 2 coag neg staph",31+2,1335,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf162,GSM1404271,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,positive(coag neg staph),"2 separate blood cultures coag neg staph, csf no growth",27+6,1130,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf164,GSM1404272,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,Yes,positive(kelbsiella oxytoca),not stated,31+5,820,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf191,GSM1404273,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,positive(E coli),csf no growth,37+0,2970,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf198,GSM1404274,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,positive(coag neg staph),"csf no growth, note CoNeg Staph resistant to fluclox and gent which baby on further deterioration and repeat sample thoughâ€¦",33+1,1070,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Platform Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con006,GSM1404275,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,41+3,4240,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con014,GSM1404276,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,na,no,38+3,2970,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Con179,GSM1404277,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,na,no,34+0,1960,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf012,GSM1404278,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"CSF: enterovirus on PCR.  CSF also grew coag neg staph, CSF WCC 300, RBC 9",34+6,2150,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf032,GSM1404279,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"yes CSF grew Listeria monocytogenes, CSF white cell count 551, RBC 119, urine no growth",41+1,3180,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf107,GSM1404280,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Coagulase -ve Staph. Aureus,BC next day also coag neg staph and line tip 2 days later.  ETS refer back to sample from 2 days previous where positive for ureaplasma and mycoplasma.,24+1,655,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf118,GSM1404281,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,Coagulase -ve Staph. Aureus,CSF negative,37+3,940,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf137,GSM1404282,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,Yes,Coagulase -ve Staph. Aureus,"long line tip also coag neg staph, coag neg staph from blood culture 6 days previously",35+1,1150,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf155,GSM1404283,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,Klebsiella pneumoniae,no,28+3,840,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Inf161,GSM1404284,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,Klebsiella oxytoca,csf klebsiella oxytoca but blood stained,29+2,1090,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Validation Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus002,GSM1404285,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,41+1,3480,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus005,GSM1404286,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,34+5,750,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus008,GSM1404287,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,33+0,1370,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus010,GSM1404288,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,38+0,3660,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus011,GSM1404289,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"right eye swab coag neg staph (likely colonisation), csf negative",35+0,2510,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus013,GSM1404290,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,40+0,3530,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus019,GSM1404291,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,29+0,1510,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus020,GSM1404292,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,34+0,1930,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus024,GSM1404293,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,34+0,2170,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus025,GSM1404294,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,34+0,2210,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus026,GSM1404295,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,35+0,2725,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus027,GSM1404296,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,41+0,3615,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus033,GSM1404297,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,35+0,1840,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus034,GSM1404298,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,"no, 2 days later had serratia marcesens in ET secretions",29+0,1490,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus035,GSM1404299,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,41+1,4860,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus036,GSM1404300,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,41+0,3360,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus037,GSM1404301,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,over previous 5 days had coliforms and S.aureus in NP/ET secretions,30+4,700,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus038,GSM1404302,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,29+0,1130,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus039,GSM1404303,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,29+0,1345,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus041,GSM1404304,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,29+4,1750,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus044,GSM1404305,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,36+0,2550,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus053,GSM1404306,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,35+0,2230,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus054,GSM1404307,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,37+0,3080,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus055,GSM1404308,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,41+1,4520,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus057,GSM1404309,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,37+0,2985,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus059,GSM1404310,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,41+1,3600,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus061,GSM1404311,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,31+2,1210,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus064,GSM1404312,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,ET tip and eye swabs positive for Ecoli,26+4,970,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus068,GSM1404313,RNA,peripheral blood,Homo sapiens,,Male,peripheral blood,No,negative,no,40+1,3680,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
GEO,2014-06-04,2014-08-12,2016-06-14,Sus074,GSM1404314,RNA,peripheral blood,Homo sapiens,,Female,peripheral blood,No,negative,no,34+0,2220,total RNA,"RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.",biotin,"Biotinylated cRNA were prepared using a linear amplification method using tailed oligo dT priming of total RNA. 500ng of total RNA was used with the manual target preparation protocol from Codelink Expression Bioarray System (GE/Amersham Biosciences). Double stranded cDNA synthesis was performed with a T7oligo (dT) primer, containing a T7 RNA polymerase promoter site added to the 3â€™. The cDNA is used as a template for in vitro transcription with biotin labeled nucleotides and the labeled cRNA used for hybridization ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).",10ug of biotinylated cRNA was hybridised overnight at 37oC in 260ul hybridisation mix as described in the standard CodeLink hybridization protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ),The bioarrays are then dried and scanned on the Agilent G2567A scanner at 5 um resolution using a standard CodeLink scanning protocol ( http://www.appliedmicroarrays.com/back_up/CodeLink.html ).,Suspected Infected Test Set,Raw data were obtained from the scanned images using CodeLinkTM EXPv4.1 (GE Healthcare) feature extraction software. Subsequent data validation comprising data quality control and normalisation involved the use of the statistical software package R/Bioconductor. Raw scan data were background subtracted and subsequently normalised using the Robust Multi-array Average (RMA) method.,
